Yiwei Qi

539 total citations
21 papers, 406 citations indexed

About

Yiwei Qi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yiwei Qi has authored 21 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yiwei Qi's work include Pituitary Gland Disorders and Treatments (3 papers), Immune cells in cancer (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Yiwei Qi is often cited by papers focused on Pituitary Gland Disorders and Treatments (3 papers), Immune cells in cancer (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Yiwei Qi collaborates with scholars based in China, United States and Germany. Yiwei Qi's co-authors include Ram Sasisekharan, Ganesh Venkataraman, Zachary Shriver, Dongfang Liu, Ganlin Zhao, Róbert Langer, Qi Zhang, Xiaojin Liu, Ting Lei and Xingbo Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and British Journal of Pharmacology.

In The Last Decade

Yiwei Qi

20 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiwei Qi China 10 202 117 83 62 41 21 406
Maria Luisa D’Angelo Italy 11 224 1.1× 204 1.7× 118 1.4× 33 0.5× 38 0.9× 12 442
Shardul Bhilocha United States 6 231 1.1× 113 1.0× 56 0.7× 75 1.2× 85 2.1× 8 511
Birgit A. Neudecker United States 7 251 1.2× 173 1.5× 128 1.5× 33 0.5× 29 0.7× 9 468
Andrew E. Whiteley United States 3 197 1.0× 52 0.4× 99 1.2× 38 0.6× 19 0.5× 5 364
Gulshan Sunavala‐Dossabhoy United States 14 288 1.4× 98 0.8× 37 0.4× 70 1.1× 31 0.8× 30 474
Jakub Kryczka Poland 13 192 1.0× 68 0.6× 104 1.3× 35 0.6× 34 0.8× 23 381
Rosalind C. Williamson United Kingdom 11 262 1.3× 171 1.5× 35 0.4× 52 0.8× 31 0.8× 17 505
L. Francisco Lorenzo‐Martín Spain 12 278 1.4× 54 0.5× 74 0.9× 32 0.5× 25 0.6× 37 466
Jiasi Zhang China 11 256 1.3× 44 0.4× 142 1.7× 77 1.2× 35 0.9× 26 476
Yvonne W. Elderkamp Netherlands 5 497 2.5× 72 0.6× 117 1.4× 54 0.9× 79 1.9× 5 725

Countries citing papers authored by Yiwei Qi

Since Specialization
Citations

This map shows the geographic impact of Yiwei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Qi more than expected).

Fields of papers citing papers by Yiwei Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Qi. The network helps show where Yiwei Qi may publish in the future.

Co-authorship network of co-authors of Yiwei Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwei Qi. A scholar is included among the top collaborators of Yiwei Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwei Qi. Yiwei Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Zhuo, Xiaojin Liu, Biao Xing, et al.. (2024). Connexin 36 Mediated Intercellular Endoplasmic Reticulum Stress Transmission Induces SSTA Resistance in Growth Hormone Pituitary Adenoma. International Journal of Biological Sciences. 20(2). 801–817. 3 indexed citations
3.
Qi, Yiwei, Wenchang Lv, Xiaojin Liu, et al.. (2023). Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype. BioMed Research International. 2023(1). 6082635–6082635. 6 indexed citations
4.
Zhang, Jun, Shengwen Liu, Yaqi Wu, et al.. (2023). Enlarged Perivascular Space and Index for Diffusivity Along the Perivascular Space as Emerging Neuroimaging Biomarkers of Neurological Diseases. Cellular and Molecular Neurobiology. 44(1). 14–14. 11 indexed citations
6.
Li, Ran, Haiyan Chen, Yiwei Qi, et al.. (2023). The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. BMC Bioinformatics. 24(1). 274–274. 9 indexed citations
7.
Xing, Biao, Qian Jiang, Zhuo Zhang, et al.. (2023). A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma. Neuro-Oncology. 26(1). 137–152. 5 indexed citations
8.
Liu, Xiaojin, Yiwei Qi, Feng Hu, Kai Shu, & Ting Lei. (2022). Differential centrifugation enhances the anti-tumor immune effect of tumor lysate-pulsed dendritic cell vaccine against glioblastoma*. Oncology and Translational Medicine. 8(5). 209–216.
9.
Qi, Yiwei, et al.. (2022). Tuberculosis-Specific Antigen/Phytohemagglutinin Ratio Combined With GeneXpert MTB/RIF for Early Diagnosis of Spinal Tuberculosis: A Prospective Cohort Study. Frontiers in Cellular and Infection Microbiology. 12. 781315–781315. 9 indexed citations
10.
Li, Shuyu, Nan Zhang, Hao Zhang, et al.. (2022). ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas. Frontiers in Oncology. 12. 844144–844144. 33 indexed citations
11.
Liu, Xiaojin, Yuan Liu, Yiwei Qi, et al.. (2022). Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells. Frontiers in Oncology. 12. 822085–822085. 16 indexed citations
13.
He, Xiao, Yiwei Qi, Xian Zhang, et al.. (2021). Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance. Cell Death and Disease. 12(12). 1145–1145. 35 indexed citations
14.
Qi, Yiwei, Xiaojin Liu, Xueyan Wan, et al.. (2021). Neurosurgery resumption in Wuhan during the early post-epidemic period: what should we pay attention to?. Neurosurgical Review. 44(6). 3509–3517. 1 indexed citations
15.
Wan, Xueyan, Zhi Cai, Yiwei Qi, et al.. (2021). MicroRNAs in Dopamine Agonist-Resistant Prolactinoma. Neuroendocrinology. 112(5). 417–426. 8 indexed citations
16.
Chang, Xiaoai, et al.. (2021). Exploiting D2 receptor β‐arrestin2‐biased signalling to suppress tumour growth of pituitary adenomas. British Journal of Pharmacology. 178(17). 3570–3586. 5 indexed citations
17.
Qi, Yiwei, et al.. (2017). Primary bone lymphoma of radius and tibia. Medicine. 96(15). e6603–e6603. 7 indexed citations
18.
Qi, Yiwei, Ganlin Zhao, Dongfang Liu, et al.. (2004). Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proceedings of the National Academy of Sciences. 101(26). 9867–9872. 48 indexed citations
19.
Liu, Dongfang, Zachary Shriver, Yiwei Qi, Ganesh Venkataraman, & Ram Sasisekharan. (2002). Dynamic Regulation of Tumor Growth and Metastasis by Heparan Sulfate Glycosaminoglycans. Seminars in Thrombosis and Hemostasis. 28(1). 67–78. 74 indexed citations
20.
Venkataraman, Ganesh, Zachary Shriver, Rahul Raman, et al.. (2001). Probing Fibroblast Growth Factor Dimerization and Role of Heparin-like Glycosaminoglycans in Modulating Dimerization and Signaling. Journal of Biological Chemistry. 276(26). 23421–23429. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026